| scholarly article | Q13442814 |
| P50 | author | E L Thomas | Q71602646 |
| Jameel M Inal | Q46581497 | ||
| P2093 | author name string | Geoffrey W Guy | |
| Jimmy D Bell | |||
| Sigrun Lange | |||
| Uchini S Kosgodage | |||
| Alistair V Nunn | |||
| Aine B Henley | |||
| Rhys Mould | |||
| P2860 | cites work | Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. | Q53660624 |
| Mitochondrial dysfunction in cancer | Q58556263 | ||
| Bax activators potentiate coated-platelet formation | Q80256973 | ||
| Prohibitin: a potential therapeutic target in tyrosine kinase signaling | Q89700562 | ||
| Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy | Q46202379 | ||
| Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility. | Q46308335 | ||
| Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets. | Q46456043 | ||
| Interorganelle Communication between Mitochondria and the Endolysosomal System. | Q47098553 | ||
| Cannabinoid-induced changes in respiration of brain mitochondria. | Q48559854 | ||
| Microvesicles released constitutively from prostate cancer cells differ biochemically and functionally to stimulated microvesicles released through sublytic C5b-9. | Q48678700 | ||
| Shedding light on the cell biology of extracellular vesicles | Q50018560 | ||
| Microvesicles: novel biomarkers for neurological disorders | Q21129259 | ||
| Syndecan-syntenin-ALIX regulates the biogenesis of exosomes | Q24337195 | ||
| Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles | Q24337853 | ||
| Microvesicles: mediators of extracellular communication during cancer progression | Q24628728 | ||
| Extracellular Vesicles and a Novel Form of Communication in the Brain | Q26750015 | ||
| Mitochondrial Stat3, the Need for Design Thinking | Q26750616 | ||
| Exosomes as mediators of neuroinflammation | Q26865141 | ||
| Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis | Q28070177 | ||
| Multifaceted role of prohibitin in cell survival and apoptosis | Q28087391 | ||
| Using exosomes, naturally-equipped nanocarriers, for drug delivery | Q28265872 | ||
| Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells | Q28468669 | ||
| Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin | Q28539631 | ||
| Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages | Q28610313 | ||
| Exosomes: composition, biogenesis and function | Q29547721 | ||
| Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
| Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles | Q29620600 | ||
| Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo. | Q30404427 | ||
| Directional cell movement through tissues is controlled by exosome secretion | Q30650966 | ||
| Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy | Q30823413 | ||
| Circulating microparticles: pathophysiology and clinical implications. | Q33373336 | ||
| Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus | Q33624336 | ||
| Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles | Q34026858 | ||
| Cannabidiol: an overview of some pharmacological aspects | Q34157378 | ||
| A combined preclinical therapy of cannabinoids and temozolomide against glioma | Q34158337 | ||
| Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy | Q34184655 | ||
| Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles | Q34455456 | ||
| Cannabidiol as a Potential Treatment for Anxiety Disorders | Q34492624 | ||
| Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes | Q34625932 | ||
| Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease | Q34627188 | ||
| Safety and side effects of cannabidiol, a Cannabis sativa constituent | Q34634008 | ||
| Cannabidiol as potential anticancer drug | Q34637516 | ||
| Exosomes released from breast cancer carcinomas stimulate cell movement | Q35208040 | ||
| Therapeutic applications of extracellular vesicles: clinical promise and open questions | Q35654719 | ||
| Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1. | Q38971037 | ||
| Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. | Q38979812 | ||
| Calcium regulates cell death in cancer: Roles of the mitochondria and mitochondria-associated membranes (MAMs). | Q39087410 | ||
| Targeting calcium signaling in cancer therapy | Q39101957 | ||
| Review: Extracellular Vesicles in Joint Inflammation. | Q39144067 | ||
| Cannabidiol: State of the art and new challenges for therapeutic applications | Q39148525 | ||
| The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy | Q39155959 | ||
| Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma | Q39156798 | ||
| Glycoconjugates from extracellular vesicles: Structures, functions and emerging potential as cancer biomarkers | Q39203224 | ||
| Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. | Q39222362 | ||
| Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. | Q39224333 | ||
| The calcium-cancer signalling nexus. | Q39225329 | ||
| Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons? | Q39328391 | ||
| Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release? | Q39354673 | ||
| Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. | Q39393896 | ||
| Current knowledge on exosome biogenesis and release | Q39451543 | ||
| Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells. | Q39648167 | ||
| Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells - possible role in SLE. | Q39685213 | ||
| Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. | Q39860485 | ||
| Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. | Q39881941 | ||
| Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. | Q40402511 | ||
| Exosome release is regulated by a calcium-dependent mechanism in K562 cells | Q40663638 | ||
| The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness | Q40986966 | ||
| Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy | Q42229140 | ||
| Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. | Q42722682 | ||
| Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes | Q42964808 | ||
| Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. | Q35659250 | ||
| Mitochondrial Ca²⁺ and membrane potential, an alternative pathway for Interleukin 6 to regulate CD4 cell effector function | Q35662424 | ||
| Mitochondrial STAT3: Powering up a potent factor | Q36043074 | ||
| Molecular Targets of Cannabidiol in Neurological Disorders | Q36157649 | ||
| Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma | Q36347143 | ||
| Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration | Q36384373 | ||
| Tumour exosome integrins determine organotropic metastasis. | Q36677568 | ||
| Mitochondria: the hub of cellular Ca2+ signaling | Q37133622 | ||
| Function of mitochondrial Stat3 in cellular respiration | Q37378567 | ||
| Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death | Q37424055 | ||
| Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. | Q37438142 | ||
| Mechanisms of microparticle generation: on the trail of the mitochondrion! | Q37806993 | ||
| Microvesicles in health and disease. | Q37981578 | ||
| Microglial microvesicle secretion and intercellular signaling. | Q38015845 | ||
| Mitochondria as sensors and regulators of calcium signalling | Q38031124 | ||
| P2X7 receptor regulation of non-classical secretion from immune effector cells | Q38033709 | ||
| The role of microvesicles in cancer progression and drug resistance. | Q38077244 | ||
| Blood/plasma secretome and microvesicles | Q38099454 | ||
| Biogenesis and secretion of exosomes. | Q38222777 | ||
| A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy | Q38443364 | ||
| The use of cannabinoids as anticancer agents. | Q38527104 | ||
| Microvesicles in the brain: Biomarker, messenger or mediator? | Q38623975 | ||
| The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer | Q38639852 | ||
| Cancer: Mitochondrial Origins | Q38654168 | ||
| Exosome secretion promotes chemotaxis of cancer cells | Q38719158 | ||
| Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression | Q38737082 | ||
| Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death | Q38754109 | ||
| Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. | Q38769897 | ||
| Extracellular vesicles as new players in angiogenesis | Q38788076 | ||
| Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells | Q38833830 | ||
| Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone | Q38835369 | ||
| Prostate cancer cells stimulated by calcium-mediated activation of protein kinase C undergo a refractory period before re-releasing calcium-bearing microvesicles. | Q38896507 | ||
| Biology and biogenesis of shed microvesicles | Q38919574 | ||
| Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery | Q38969541 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| cannabidiol | Q422917 | ||
| cannabinoids | Q422936 | ||
| P304 | page(s) | 889 | |
| P577 | publication date | 2018-08-13 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer | |
| P478 | volume | 9 |
| Q91962788 | A Novel, Tumor-Induced Osteoclastogenesis Pathway Insensitive to Denosumab but Interfered by Cannabidiol |
| Q60929868 | Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells |
| Q92210214 | Cannabidiol Induces Cell Cycle Arrest and Cell Apoptosis in Human Gastric Cancer SGC-7901 Cells |
| Q90267081 | Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles |
| Q92882770 | Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma-An Overview |
| Q64100363 | Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance |
| Q90289880 | From sunscreens to medicines: Can a dissipation hypothesis explain the beneficial aspects of many plant compounds? |
| Q90168397 | ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts |
| Q89879539 | Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines |
| Q60927782 | Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme |
Search more.